About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
All
2024
2023
2022
2021
2020
2019
29
Jul
2021
16:06 E.S.T.
Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT
Read more
14
Jun
2021
14:11 E.S.T.
Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities
Read more
02
Jun
2021
02:35 E.S.T.
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021
Read more
11
May
2021
13:05 E.S.T.
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
Read more
06
May
2021
14:28 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Read more
26
Apr
2021
15:06 E.S.T.
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021
Read more
09
Apr
2021
00:00 E.S.T.
Cellectis Completes Sale of $47 million through its ATM program
Read more
29
Mar
2021
14:48 E.S.T.
Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq
Read more
04
Mar
2021
14:59 E.S.T.
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results
Read more
25
Feb
2021
15:29 E.S.T.
Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST
Read more
Prev
1
2
3
Next